InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Holders of 5% or more of INM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of InMed Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 13G | 24.10%800.0K shares | New | Jun 5, 20261 filing | Jun 5, 2026 | SEC |
| Vivo Opportunity Fund Holdings, L.P. | 13D | 21.70%718.4K shares | New | Jun 10, 20261 filing | Jun 10, 2026 | SEC |
| YA II PN, Ltd. | 13G | 9.99%80.4K shares | New | Dec 18, 20241 filing | Dec 18, 2024 | SEC |
| Sabby Management, LLC | 13G | 9.90%280.1K shares | New | Jan 20, 20261 filing | Jan 20, 2026 | SEC |
| Squadron Capital Management LLC | 13G | 9.80%325.0K shares | New | May 27, 20261 filing | May 27, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
12 Schedule 13D and 13G filings on InMed Pharmaceuticals Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20269:12 PM ET | Ikarian Capital, LLCand 1 other | 13G | 4.20%137.6K shares | NewBelow 5% | Jun 30, 2026 | SEC |
| Jun 10, 20269:32 PM ET | Vivo Opportunity Fund Holdings, L.P.and 3 others | 13D | 21.70%718.4K shares | New | May 19, 2026 | SEC |
| Jun 5, 20264:44 PM ET | ADAR1 Capital Management, LLCand 1 other | 13G | 24.10%800.0K shares | New | May 31, 2026 | SEC |
| May 27, 20264:08 PM ET | Squadron Capital Management LLCand 3 others | 13G | 9.80%325.0K shares | New | May 19, 2026 | SEC |
| Jan 20, 20262:25 PM ET | Sabby Management, LLCand 2 others | 13G | 9.90%280.1K shares | New | Dec 31, 2025 | SEC |
| Apr 2, 20254:13 PM ET | AdvisorShares Trust | 13G/A | 0.00%0 shares | –Below 5% | Mar 31, 2025 | SEC |
| Jan 3, 20254:17 PM ET | Sabby Management, LLCand 2 others | 13G/A | 4.90%36.1K shares | –Below 5% | Dec 31, 2024 | SEC |
| Dec 18, 20248:05 AM ET | YA II PN, Ltd.and 7 others | 13G | 9.99%80.4K shares | New | Dec 13, 2024 | SEC |
| Feb 14, 2023 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 4, 2022 | Hudson Bay Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2021 | Hudson Bay Capital Management LP | 13GOld format | – | New | – | SEC |
| Jan 20, 2021 | Empery Asset Management, LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell InMed Pharmaceuticals Inc. shares.
No Form 144 notices for InMed Pharmaceuticals Inc. are on file.